000 | 01146 a2200313 4500 | ||
---|---|---|---|
005 | 20250517040213.0 | ||
264 | 0 | _c20160614 | |
008 | 201606s 0 0 eng d | ||
022 | _a1879-0712 | ||
024 | 7 |
_a10.1016/j.ejphar.2015.06.025 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMeijers, Wouter C | |
245 | 0 | 0 |
_aGalectin-3 and post-myocardial infarction cardiac remodeling. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cSep 2015 |
||
300 |
_a115-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aFibrosis |
650 | 0 | 4 |
_aGalectin 3 _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
700 | 1 | _avan der Velde, A Rogier | |
700 | 1 | _aPascual-Figal, Domingo A | |
700 | 1 | _ade Boer, Rudolf A | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 763 _gno. Pt A _gp. 115-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2015.06.025 _zAvailable from publisher's website |
999 |
_c25007729 _d25007729 |